CMMB Chemomab Therapeutics Ltd.

NASDAQ
$2.58

Chemomab Therapeutics Ltd. (CMMB) SEC Filings

Everything CMMB has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

4 filings
Date Form Filing
SCHEDULE 13D/A
4
6-K Acquisition Disposition · Capital Raise · Earnings Release · Executive Change · Guidance Update
4

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.